NUNTIUS THERAPEUTICS LIMITED
NUNTIUS THERAPEUTICS LIMITED
Registered number: 13130725
Unaudited Financial Statements
For the Period
13 January 2021
to
31 January 2022
Daly Accounting
The Cobalt Building
1600 Eureka Park, Lower Pemberton
Ashford
Kent
TN25 4BF
NUNTIUS THERAPEUTICS LIMITED
Unaudited Financial Statements
For the Period
13 January 2021
to
31 January 2022
Unaudited Financial Statements
| Contents | |
| Page | |
|---|---|
| Balance Sheet | 1—2 |
| Notes to the Financial Statements | 3—5 |
NUNTIUS THERAPEUTICS LIMITED
Balance Sheet
As at
31 January 2022
Balance Sheet
Registered number:
13130725
For the period ending 31 January 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
| 31 January 2022 | |||
|---|---|---|---|
| Notes | £ | £ | |
| FIXED ASSETS | |||
| Tangible Assets | 3 |
|
|
|
|
|||
| CURRENT ASSETS | |||
| Debtors | 4 |
|
|
| Cash at bank and in hand |
|
||
|
|
|||
| Creditors: Amounts Falling Due Within One Year | 5 |
( |
|
| NET CURRENT ASSETS (LIABILITIES) |
( |
||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
||
| NET LIABILITIES |
( |
||
| CAPITAL AND RESERVES | |||
| Called up share capital | 6 |
|
|
| Profit and Loss Account |
( |
||
| SHAREHOLDERS' FUNDS | (536,928) | ||
NUNTIUS THERAPEUTICS LIMITED
Balance Sheet (continued)
As at
31 January 2022
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
|
Director
|
|
|
The notes on pages 3 to 5 form part of these financial statements.
NUNTIUS THERAPEUTICS LIMITED
Notes to the Financial Statements
For the Period
13 January 2021
to
31 January 2022
Notes to the Financial Statements
1.
Accounting Policies
1.1.
Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
1.2.
Going Concern Disclosure
The Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The financial statements have therefore been prepared on the going concern basis.
1.3.
Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
| Plant & Machinery |
|
| Fixtures & Fittings |
|
| Computer Equipment |
|
1.4.
Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
1.5.
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Corporation tax credits are recognised as income in the period necessary to match them with the related costs they are intended to incentivise and when all relevant qualyfing conditions have been met.
2.
Average Number of Employees
Average number of employees, including directors, during the year was: 3
3.
Tangible Assets
| Plant & Machinery | Fixtures & Fittings | Computer Equipment | Total | |
|---|---|---|---|---|
| £ | £ | £ | £ | |
| Cost | ||||
| As at
|
|
|
|
|
| Additions |
|
|
|
|
| As at
|
|
|
|
|
| Depreciation | ||||
| As at
|
|
|
|
|
| Provided during the period |
|
|
|
|
| As at
|
|
|
|
|
| Net Book Value | ||||
| As at
|
|
|
|
|
| As at
|
|
|
|
|
NUNTIUS THERAPEUTICS LIMITED
Notes to the Financial Statements (continued)
For the Period
13 January 2021
to
31 January 2022
4.
Debtors
| 31 January 2022 | |
|---|---|
| £ | |
| Due within one year | |
| Prepayments and accrued income |
|
| Other debtors |
|
| Corporation tax recoverable assets |
|
| VAT |
|
|
|
|
5.
Creditors: Amounts Falling Due Within One Year
| 31 January 2022 | |
|---|---|
| £ | |
| Trade creditors |
|
| Other taxes and social security |
|
| Accruals and deferred income |
|
| Directors' loan accounts |
|
| Amounts owed to group undertakings |
|
|
|
|
NUNTIUS THERAPEUTICS LIMITED
Notes to the Financial Statements (continued)
For the Period
13 January 2021
to
31 January 2022
7.
Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
| Land and buildings | |
|---|---|
| 31 January 2022 | |
| £ | |
| Within 1 year | 17,510 |
| 17,510 | |
8.
Ultimate Controlling Party
The company's immediate and ultimate parent undertaking is NUNTIUS THERAPEUTICS INC., a company incorporated in the United States of America.
The directors consider there to be no ultimate controlling party.
9.
General Information
NUNTIUS THERAPEUTICS LIMITED
is a private company, limited by shares, incorporated in England & Wales, registered number
13130725
. The registered office is Unit 013 Westbourne Studios, 242 Acklam Road, London, W10 5JJ.